You are here: Industry Insights > Naloxone

News List

Opioid Overdose Antidote Urged for Schools After Student's Fentanyl Death drugs.com
January 24, 2022
Schools should stock the opioid overdose antidote naloxone and train staff and students how to respond...
Wearable Device Spots, Reverses Opioid Overdoses Drugs
November 25, 2021
A wearable device that could inject a lifesaving antidote for an opioid overdose might be on the horizon.
FDA approves naloxone injection to counteract opioid overdoses FDA
October 20, 2021
Action: FDA has approved ZIMHI (naloxone hydrochloride) injection as an additional option to treat opioid overdose. ZIMHI is administered using a single-dose, prefilled syringe that delivers 5 milligrams (mg) ...
Hikma Pharma get US FDA nod for higher dosage of nasal spray product to treat opioid overdose expresspharma
May 07, 2021
The US Food and Drug Administration (US FDA) announced the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.
Hikma get US FDA nod for higher dosage of naloxone nasal spray to treat opioid overdose expresspharma
May 07, 2021
The US Food and Drug Administration (US FDA) announced the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.
FDA Recommends Discussing Naloxone When Prescribing Opioids, Opioid Use Disorder Treatments americanpharmaceuticalreview
July 28, 2020
To reduce the risk of death from opioid overdose, the U.S. Food and Drug Administration (FDA) is making the following recommendations about the opioid reversal medicine, naloxone.
FDA orders update of label change for opioid pain medications europeanpharmaceuticalreview
July 27, 2020
The FDA is requiring that labels for opioid pain medicine and medicines to treat opioid use disorder recommend healthcare professionals discuss the availability of naloxone with patients to reduce overdoses.
Just 2% of Patients Who Need It Get Anti-Opioid Drug Naloxone drugs
January 19, 2020
Naloxone can prevent opioid overdose deaths, but only a tiny percentage of Americans at risk are prescribed the lifesaving drug. That's the key finding from an analysis of nationwide data on adults with private health insurance.
FDA Statement on Efforts to Increase Availability of all Forms of Naloxone americanpharmaceuticalreview
September 24, 2019
Addressing opioid overdose continues to be one of the most urgent public health priorities for the U.S. government and making potentially lifesaving treatments more readily available is one of the top ways we can ...
Too Few U.S. Opioid Users Are Getting OD Antidote drugs
August 07, 2019
Naloxone can reverse an opioid overdose, but far too little of the lifesaving drug is used where it is needed the most, a new U.S. government report shows.

Previous page 1 2 Next page